维普中文期刊产品整合服务
9篇 您的检索式:作者名="Alatrash"
    题名 作者 年代 出处 被引量
1Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b:phase Ⅰ trial of patients with metastatic renal cell carcinoma or malignant melanoma显示文摘Alatrash G Hutson TE Molto L 2004J Clin Oncol2004,22,14:1
2Experimenta and analytical investigations of primary coolant pump coastdown phenomena for the Jordan Research and Training Reactor显示文摘ALATRASH Y KANG H O YOON H G 2015Nuclear Engineering and Design2015,286,:1
3Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an antieancer adaptive immune response显示文摘Mittendorf EA Alatrash G Qiao N et el 0,,13:1
4Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response 显示文摘Mittendorf EA Alatrash G Qiao N 2012Cancer Res2012,72,13:1
5Clinical and Immunologic Effects of SubcutaneOusly Administered Interleukin-12 and Interfeton Alfa-2b:Phase I Tria of Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma显示文摘Alatrash G Hutson TE Molto L 2004J Clin Oncol2004,22,14:1
6Platelet recovery be- fore allogeneic stem cell transplantation predicts posttransplan- tation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome 显示文摘Alatrash G Pelosini M Saliba RM 2011Biol Blood Marrow Trans- plate2011,17,12:1
7Clinical and Immunologic Effects of Subcutaneously Administered Interleukin-12 and Interferon Alfa-2b:Phase I Trial of Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma显示文摘Gheath Alatrash Thomas E.Hutson Luis Molto 0,,14:1
8Breast cancer vaccines:ongoing National Cancer Institute-registered clinical trials显示文摘Mittendorf EA Alatrash G Xiao H 2011Expert Rev Vaccines2011,10,6:1
9Breast cancer vaccines:ongoing National Cancer Institute-registered clinical trials显示文摘Mittendorf EA Alatrash G Xiao H 0,,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费